Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04051996
Title GLAD-AML - Glasdegib (Pf-04449913) With Two Standard Decitabine Regimens for Older Patients With Poor-risk Acute Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Yale University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST